InnoCan Pharma (InnoCan Pharma) Change In Other Working Capital : $0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is InnoCan Pharma Change In Other Working Capital?

InnoCan Pharma's Change In Other Working Capital for the quarter that ended in Mar. 2024 was $0.00 Mil. It means InnoCan Pharma's Other Working Capital increased by $0.00 Mil from Dec. 2023 to Mar. 2024 .

InnoCan Pharma's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $-0.00 Mil. It means InnoCan Pharma's Other Working Capital declined by $0.00 Mil from Dec. 2022 to Dec. 2023 .

InnoCan Pharma Change In Other Working Capital Historical Data

The historical data trend for InnoCan Pharma's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Change In Other Working Capital Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Other Working Capital

Get a 7-Day Free Trial

-0.26

InnoCan Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Other Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

InnoCan Pharma Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

InnoCan Pharma Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma (InnoCan Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (OTCPK:INNPF) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

IP4:Germany INNO:Canada

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.